# Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma

> **NCT00116441** · PHASE1,PHASE2 · COMPLETED · sponsor: **Cell Genesys** · enrollment: 22 (—)

## Conditions studied

- Multiple Myeloma

## Interventions

- **BIOLOGICAL:** Therapeutic Cellular Vaccine, GM-CSF Producing

## Key facts

- **NCT ID:** NCT00116441
- **Lead sponsor:** Cell Genesys
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** 22 (—)
- **Last updated:** 2007-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00116441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00116441, "Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00116441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*